tv.qiagenbioinformatics.com marketingbiox@qiagen.com https://tv.qiagenbioinformatics.com Watch tutorials, interviews and much more on our web based TV channel! en-us Visualplatform http://blogs.law.harvard.edu/tech/rss tv.qiagenbioinformatics.com CLC bio TV Watch tutorials, interviews and much more on our web based TV channel! clc bio tv, bioinformatics, genomics, research episodic no https://tv.qiagenbioinformatics.com/files/rv0.0/sitelogo.gif https://tv.qiagenbioinformatics.com http://tv.qiagenbioinformatics.com/photo/83037544/take-your-genome-research-to-the <p>Discovery of new genes implicated in hereditary diseases or cancer progression is challenging and advancing rapidly with an increase in the amount of cohort data to analyze. It is estimated that every day one new gene is discovered to be associated with a disease. QCI Interpret Translational can get your research to the next level by providing you all the necessary analysis tools with the world’s most comprehensive and up-to-date curated scientific evidence. Get valuable and reliable insights for your research project and speed up your discoveries by using a streamlined NGS analysis workflow in a user-friendly interface without needing bioinformatics expertise.<p></p> <p>In this webinar, viewers will have the opportunity to:</p> <p>Explore capabilities which can enable them to accelerate discoveries from hereditary or tumor cohort analyses<br> Discover interactive tools with current and comprehensive associations between gene variants and diseases<br> Learn how these resources are supported by unique curated content among other integrated scientific evidence</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/83037544/take-your-genome-research-to-the"><img src="http://tv.qiagenbioinformatics.com/64968578/83037544/8590517c0bfb9884a7aaddd459997d73/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/83037544 Fri, 03 Feb 2023 04:39:38 GMT Take your genome research to the next level with QCI Interpret Translational Discovery of new genes implicated in hereditary diseases or cancer progression is challenging and advancing rapidly with an increase in the amount of cohort data to analyze. It is estimated that every day one new gene is discovered to be associated with a disease. QCI Interpret Translational can get your research to the next level by providing you all the necessary analysis tools with the world’s most comprehensive and up-to-date curated scientific evidence. Get valuable and reliable insights for your research project and speed up your discoveries by using a streamlined NGS analysis workflow in a user-friendly interface without needing bioinformatics expertise. In this webinar, viewers will have the opportunity to: Explore capabilities which can enable them to accelerate discoveries from hereditary or tumor cohort analyses Discover interactive tools with current and comprehensive associations between gene variants and diseases Learn how these resources are supported by unique curated content among other integrated scientific evidence Discovery of new genes implicated in hereditary diseases or cancer progression is challenging and advancing rapidly with an increase in the amount of cohort data to analyze. It is estimated that every day one new gene is discovered to be... tv.qiagenbioinformatics.com 43:12 <p>Discovery of new genes implicated in hereditary diseases or cancer progression is challenging and advancing rapidly with an increase in the amount of cohort data to analyze. It is estimated that every day one new gene is discovered to be associated with a disease. QCI Interpret Translational can get your research to the next level by providing you all the necessary analysis tools with the world’s most comprehensive and up-to-date curated scientific evidence. Get valuable and reliable insights for your research project and speed up your discoveries by using a streamlined NGS analysis workflow in a user-friendly interface without needing bioinformatics expertise.<p></p> <p>In this webinar, viewers will have the opportunity to:</p> <p>Explore capabilities which can enable them to accelerate discoveries from hereditary or tumor cohort analyses<br> Discover interactive tools with current and comprehensive associations between gene variants and diseases<br> Learn how these resources are supported by unique curated content among other integrated scientific evidence</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/83037544/take-your-genome-research-to-the"><img src="http://tv.qiagenbioinformatics.com/64968578/83037544/8590517c0bfb9884a7aaddd459997d73/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> qci interpret translational http://tv.qiagenbioinformatics.com/photo/72567132/variant-calling-to-biological <p>In this webinar, we present a case study on Lynch syndrome (LS), a hereditary condition characterized by a high risk of colorectal cancer, endometrial cancer, and other neoplasia that typically manifests in the context of germline variants in DNA mismatched genes.<br> To study whether other germline pathogenic variants of hereditary cancer genes are present in patients previously diagnosed with LS, the researchers analyzed a comprehensive panel of cancer-predisposing genes by NGS among 84 LS probands. <p>With this study as an example, we will illustrate how you can use your own data and public data to conduct translational research using 3 software solutions from QIAGEN.</p> <p>This webinar will focus on the following elements:</p> <p>Data analysis – How you can efficiently retrieve and process FASTQ data with accurate variant interpretation using CLC Genomics Workbench<br> Interpretation – How you can take a set of variants and rapidly assess sample variants for disease relevance and pathogenicity using QCI Interpret Translational<br> Discovery – How you can combine results and contextualize variant biomarkers with other public datasets using QIAGEN Ingenuity Pathway Analysis (IPA)</p> <p>Speaker:</p> <p>Eric Seiser, PhD<br> Senior Field Applications Scientist<br> QIAGEN Digital Insights</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/72567132/variant-calling-to-biological"><img src="http://tv.qiagenbioinformatics.com/64968578/72567132/3358a3e7a341f7ea5ce094fcba6bac80/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> http://tv.qiagenbioinformatics.com/photo/72567132 Thu, 09 Dec 2021 07:19:18 GMT Variant Calling to Biological Insights – A Lynch Syndrome Case Study In this webinar, we present a case study on Lynch syndrome (LS), a hereditary condition characterized by a high risk of colorectal cancer, endometrial cancer, and other neoplasia that typically manifests in the context of germline variants in DNA mismatched genes. To study whether other germline pathogenic variants of hereditary cancer genes are present in patients previously diagnosed with LS, the researchers analyzed a comprehensive panel of cancer-predisposing genes by NGS among 84 LS probands. With this study as an example, we will illustrate how you can use your own data and public data to conduct translational research using 3 software solutions from QIAGEN. This webinar will focus on the following elements: Data analysis – How you can efficiently retrieve and process FASTQ data with accurate variant interpretation using CLC Genomics Workbench Interpretation – How you can take a set of variants and rapidly assess sample variants for disease relevance and pathogenicity using QCI Interpret Translational Discovery – How you can combine results and contextualize variant biomarkers with other public datasets using QIAGEN Ingenuity Pathway Analysis (IPA) Speaker: Eric Seiser, PhD Senior Field Applications Scientist QIAGEN Digital Insights In this webinar, we present a case study on Lynch syndrome (LS), a hereditary condition characterized by a high risk of colorectal cancer, endometrial cancer, and other neoplasia that typically manifests in the context of germline variants in DNA... tv.qiagenbioinformatics.com 58:18 <p>In this webinar, we present a case study on Lynch syndrome (LS), a hereditary condition characterized by a high risk of colorectal cancer, endometrial cancer, and other neoplasia that typically manifests in the context of germline variants in DNA mismatched genes.<br> To study whether other germline pathogenic variants of hereditary cancer genes are present in patients previously diagnosed with LS, the researchers analyzed a comprehensive panel of cancer-predisposing genes by NGS among 84 LS probands. <p>With this study as an example, we will illustrate how you can use your own data and public data to conduct translational research using 3 software solutions from QIAGEN.</p> <p>This webinar will focus on the following elements:</p> <p>Data analysis – How you can efficiently retrieve and process FASTQ data with accurate variant interpretation using CLC Genomics Workbench<br> Interpretation – How you can take a set of variants and rapidly assess sample variants for disease relevance and pathogenicity using QCI Interpret Translational<br> Discovery – How you can combine results and contextualize variant biomarkers with other public datasets using QIAGEN Ingenuity Pathway Analysis (IPA)</p> <p>Speaker:</p> <p>Eric Seiser, PhD<br> Senior Field Applications Scientist<br> QIAGEN Digital Insights</p></p><p><a href="http://tv.qiagenbioinformatics.com/photo/72567132/variant-calling-to-biological"><img src="http://tv.qiagenbioinformatics.com/64968578/72567132/3358a3e7a341f7ea5ce094fcba6bac80/standard/download-7-thumbnail.jpg" width="75" height=""/></a></p> clinical qci interpret translational webinar